Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy M. Sullivan, MD, Haraldur Bjarnason, MD, Stephen Cha, MS, Peter Gloviczki, MD Journal of Vascular Surgery Volume 49, Issue 6, Pages 1472-1479.e3 (June 2009) DOI: 10.1016/j.jvs.2009.02.006 Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 1 Kaplan-Meier estimates of patient survival in (A) low-risk and (B) high-risk patients with chronic mesenteric ischemia treated with open (OR, solid line) and endovascular revascularization (ER, dashed line). Journal of Vascular Surgery 2009 49, 1472-1479.e3DOI: (10.1016/j.jvs.2009.02.006) Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 2 Kaplan-Meier estimates of survival free of recurrent symptoms in patients treated for chronic mesenteric ischemia with open (OR, solid line) or endovascular revascularization (ER, dashed line). Journal of Vascular Surgery 2009 49, 1472-1479.e3DOI: (10.1016/j.jvs.2009.02.006) Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 3 Kaplan-Meier estimates of (A) primary and (B) secondary patency rates in patients treated for chronic mesenteric ischemia with open (OR, solid line) or endovascular revascularization (ER, dashed line). Journal of Vascular Surgery 2009 49, 1472-1479.e3DOI: (10.1016/j.jvs.2009.02.006) Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 4 (online only) A, Kaplan-Meier estimates of primary and secondary patency rates in patients treated for chronic mesenteric ischemia treated with percutaneous transluminal angioplasty (PTA) or stent placement. B, Patency rates are shown for percutaneous celiac and superior mesenteric artery (SMA) interventions. Journal of Vascular Surgery 2009 49, 1472-1479.e3DOI: (10.1016/j.jvs.2009.02.006) Copyright © 2009 Society for Vascular Surgery Terms and Conditions